Recent evidence has shown that FOXA1 is essential for almost all ER binding events in breast cancer (Hurtado et al., 2011) and for ER functionality, yet our understanding of FOXA1 activity and the events involved in determining FOXA1-chromatin interactions is limited. Here, FOXA1 is linked to breast cancer.